IE 11 is not supported. For an optimal experience visit our site on another browser.

Integra LifeSciences to Present at the Deutsche Bank Health Care and the Bank of America Merrill Lynch Health Care Conferences

/ Source: GlobeNewswire

PLAINSBORO, N.J., April 28, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at two conferences in May as follows:

On Monday, May 2, 2011 at 1:30 PM ET., Mr. Brian Larkin, President, Global Spine and Orthobiologics and Head of Strategic Development, will present at the Deutsche Bank Securities 36th Annual Health Care Conference at the InterContinental Hotel in Boston.

On Tuesday, May 10, 2011 1:40 PM PT, Mr. Stuart Essig, Chief Executive Officer, will present at Bank of America Merrill Lynch's 2011 Health Care Conference at the Encore at Wynn in Las Vegas.

Both conferences will have a live webcast and post-event replay. A link to the webcasts detail will be posted on our website on the Investor Relations section at .

Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit

Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2010 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: Integra LifeSciences Holdings Corporation John B. Henneman, III Executive Vice President Finance and Administration and Chief Financial Officer (609) 275-0500 Investor Relations: Angela Steinway (609) 936-2268